EICHOR
● Completed
Gender Differences in Prevention Strategies and Therapeutic Adherence After Acute Myocardial Infarction
Condition: Gender Differences · Adherence, Medication · Therapeutic Adherence · Sponsor: Spanish Society of Cardiology
About this study
PARTICIPANT CENTERS: 25 hospitals managing routinely acute myocardial infarction (AMI) and representing different regions from Spain will be invited to participate. GENERAL OBJECTIVE: To evaluate if there are differences in the level of adherence to recommended secondary prevention therapies (pharmacological and non-pharmacological) between women and men surviving a type 1 acute myocardial infarction (with obstructive coronary artery disease), its potential consequences, and the potential factors related to that difference, if present. DESIGN: Prospective, matched cohort study of patients hospitalized for a type 1 acute myocardial infarction with evidence of obstructive coronary artery disease who are discharged home alive. Women will be enrolled first, ideally in a consecutive manner, as they are the focus of the study. Men will be recruited subsequently as the comparison group, with 1:1 matching for age and ECG presentation. Matching will be performed locally, in each study site (hospital). All patients will undergo 1-year follow-up with clinical and therapeutic adherence evaluation. \- Reference cohort: 500 women discharged alive after a hospitalization for a type 1 acute myocardial infarction with significant coronary artery disease. \- Comparator cohort: 500 age (±2 years) and ECG (ST-segment elevation acute myocardial infarction (STEMI) / non-ST-segment elevation acute myocardial infarction (NSTEMI)) locally matched men discharged alive after a hospitalization for …
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (25)
| Hospital Universitario de Santiago de Compostela | Santiago de Compostela, A Coruña, Spain | — |
| Complejo Hospitalario Universitario de Albacete | Albacete, Albacete, Spain | — |
| Hospital General Universitario de Alicante | Alicante, Alicante, Spain | — |
| Hospital Universitari Son Espases, Palma de Mallorca | Palma de Mallorca, Balearic Islands, Spain | — |
| Hospital Universitario de Bellvitge | Barcelona, Barcelona, Spain | — |
| Hospital Universitario Vall´d Hebron | Barcelona, Barcelona, Spain | — |
| Hospital Universitario Marqués de Valdecilla | Santander, Cantabria, Spain | — |
| Hospital San Pedro de Alcántara | Cáceres, Cáceres, Spain | — |
| Hospital Universitario de Gran Canaria Dr. Negrín | Las Palmas de Gran Canaria, Las Palmas, Spain | — |
| Complejo Asistencial Universitario de León | León, León, Spain | — |
| Hospital Universitario Fundación Alcorcón | Alcorcón, Madrid, Spain | — |
| Hospital Universitario 12 de Octubre | Madrid, Madrid, Spain | — |
+ 13 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05619601